GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Coloplast A/S (XTER:CBHD) » Definitions » Cyclically Adjusted PB Ratio

Coloplast A/S (XTER:CBHD) Cyclically Adjusted PB Ratio : 24.04 (As of Jun. 19, 2024)


View and export this data going back to . Start your Free Trial

What is Coloplast A/S Cyclically Adjusted PB Ratio?

As of today (2024-06-19), Coloplast A/S's current share price is €111.55. Coloplast A/S's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was €4.64. Coloplast A/S's Cyclically Adjusted PB Ratio for today is 24.04.

The historical rank and industry rank for Coloplast A/S's Cyclically Adjusted PB Ratio or its related term are showing as below:

XTER:CBHD' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 20.9   Med: 28.48   Max: 43.12
Current: 24.39

During the past years, Coloplast A/S's highest Cyclically Adjusted PB Ratio was 43.12. The lowest was 20.90. And the median was 28.48.

XTER:CBHD's Cyclically Adjusted PB Ratio is ranked worse than
97.91% of 478 companies
in the Medical Devices & Instruments industry
Industry Median: 2.03 vs XTER:CBHD: 24.39

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Coloplast A/S's adjusted book value per share data for the three months ended in Mar. 2024 was €9.655. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €4.64 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Coloplast A/S Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Coloplast A/S's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Coloplast A/S Cyclically Adjusted PB Ratio Chart

Coloplast A/S Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 32.49 37.39 35.32 24.27 22.77

Coloplast A/S Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 28.21 27.01 22.77 23.07 26.70

Competitive Comparison of Coloplast A/S's Cyclically Adjusted PB Ratio

For the Medical Instruments & Supplies subindustry, Coloplast A/S's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Coloplast A/S's Cyclically Adjusted PB Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Coloplast A/S's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Coloplast A/S's Cyclically Adjusted PB Ratio falls into.



Coloplast A/S Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Coloplast A/S's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=111.55/4.64
=24.04

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Coloplast A/S's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Coloplast A/S's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book=Book Value per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=9.655/118.4000*118.4000
=9.655

Current CPI (Mar. 2024) = 118.4000.

Coloplast A/S Quarterly Data

Book Value per Share CPI Adj_Book
201406 3.455 99.700 4.103
201409 4.009 99.700 4.761
201412 3.443 99.400 4.101
201503 4.120 100.200 4.868
201506 3.675 100.300 4.338
201509 2.986 100.200 3.528
201512 2.552 99.800 3.028
201603 3.105 100.200 3.669
201606 2.856 100.600 3.361
201609 3.212 100.200 3.795
201612 2.668 100.300 3.149
201703 3.209 101.200 3.754
201706 3.138 101.200 3.671
201709 3.768 101.800 4.382
201712 2.980 101.300 3.483
201803 3.404 101.700 3.963
201806 3.295 102.300 3.814
201809 4.051 102.400 4.684
201812 3.275 102.100 3.798
201903 3.892 102.900 4.478
201906 3.748 102.900 4.313
201909 4.359 102.900 5.016
201912 3.430 102.900 3.947
202003 4.142 103.300 4.747
202006 4.011 103.200 4.602
202009 4.682 103.500 5.356
202012 3.642 103.400 4.170
202103 4.379 104.300 4.971
202106 4.378 105.000 4.937
202109 5.162 105.800 5.777
202112 4.056 106.600 4.505
202203 4.677 109.900 5.039
202206 4.604 113.600 4.799
202209 5.248 116.400 5.338
202212 3.739 115.900 3.820
202303 4.209 117.300 4.248
202306 3.883 116.400 3.950
202309 10.325 117.400 10.413
202312 9.026 116.700 9.157
202403 9.655 118.400 9.655

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Coloplast A/S  (XTER:CBHD) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Coloplast A/S Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Coloplast A/S's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Coloplast A/S (XTER:CBHD) Business Description

Traded in Other Exchanges
Address
Holtedam 1-3, Humlebaek, DNK, DK-3050
Coloplast is a leading global competitor in ostomy management and continence care. The firm designs, manufactures, and markets ostomy care systems, disposable containment devices, paste, powder, seals, and intermittent catheters for continence care. Coloplast also maintains a tertiary presence in the urology and woundcare markets, where it manufactures and markets penile implants, slings for incontinence and prolapse, and wound dressings. The company derives more than 60% of sales from Europe, 24% from other developed countries, and 17% from the rest of the world.

Coloplast A/S (XTER:CBHD) Headlines

No Headlines